SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001140361-23-021893
Filing Date
2023-05-01
Accepted
2023-05-01 09:21:54
Documents
2
Group Members
BIOSYNEX U.S. HOLDINGS, INC.PROJECT MERCI MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D brhc20052196_sc13d.htm SC 13D 139073
2 EXHIBIT 4 brhc20052196_ex99-4.htm EX-99.4 8345
  Complete submission text file 0001140361-23-021893.txt   149173
Mailing Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788
Business Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788 (631) 924-1135
CHEMBIO DIAGNOSTICS, INC. (Subject) CIK: 0001092662 (see all company filings)

IRS No.: 880425691 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-61925 | Film No.: 23870613
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22 BOULEVARD SEBASTIEN BRANT ILLKIRCH-GRAFFENSTADEN I0 67400
Business Address 22 BOULEVARD SEBASTIEN BRANT ILLKIRCH-GRAFFENSTADEN I0 67400 33(0)670860015
Biosynex SA (Filed by) CIK: 0001964166 (see all company filings)

IRS No.: 481075703 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D